In This Section

researchcomm [at]
Location - People View

100 Penn Square East
Philadelphia, PA 19107
United States

Related People

Jeff Gerber, MD, PhD, Named Associate Chief Clinical Research Officer

Published on
Sep 13, 2019

To: Principal Investigators, Research Staff
From: Richard Aplenc, MD, AVP and Chief Clinical Research Officer
Re: Jeff Gerber, MD, PhD, Named Associate Chief Clinical Research Officer
Date: September 13, 2019

I am pleased to announce that Jeffrey Gerber, MD, PhD, has been named Associate Chief Clinical Research Officer for CHOP Research Institute. In this role, Jeff will work with me in the further development of biostatistics support services in the Research Institute. He will play a central role in the development and implementation of a new Research Institute strategy in epidemiology and health services research, which will include enhanced support and mentorship for clinical epidemiology investigators, particularly junior faculty and instructors.

Jeff is renowned as an international leader in antimicrobial stewardship research and is ideally suited for this new role at the Research Institute. In addition to being Associate Professor of Pediatrics and Epidemiology at Penn and Attending Physician in the Division of Infectious Diseases at CHOP, he holds several key leadership positions. Jeff serves as Medial Director of the Antimicrobial Stewardship Program at CHOP, Associate Director of the Center for Pediatric Clinical Effectiveness at CHOP, is a Senior Scholar in the Penn Center for Clinical Epidemiology and Biostatistics; and is a member of the American Academy of Pediatrics Committee on Infectious Diseases, for which he is Chair of the Antimicrobial Resistance and Stewardship Subcommittee.

Jeff’s research program focuses on the epidemiology and outcomes of antimicrobial use in children in both hospital and ambulatory settings. He is currently examining the impact of early-life antibiotics on the developing gut microbiome and serves as the site PI of the Penn-CHOP CDC Epicenter as well as for a clinical trial comparing antibiotic use for pediatric community-acquired pneumonia.

Please join me in congratulating Jeff on his exciting new role at CHOP!